Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 35

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 35
---
568 shares in the ATM Offering for gross proceeds of $1,994,583.

Information Regarding our Capitalization

As of June 6, 2025 we had 1,472,891 shares of
common stock issued and outstanding. Additional information regarding our issued and outstanding securities may be found under “Description of Securities.”

Unless otherwise specifically stated, information
throughout this prospectus does not assume the exercise of outstanding options or warrants to purchase shares of our common stock.

Corporate Information

Our principal executive offices are located at
1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036. Our corporate website address is 60degreespharma.com. Our telephone
number is (202) 327-5422. The information included on our website is not part of this prospectus.

Available Information

Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Exchange Act, are filed with the SEC.
Such reports and other information filed by us with the SEC are available free of charge at investors.60degreespharma.com/financial-information/sec-filings
when such reports are available on the SEC’s website. We periodically provide certain information for investors on our corporate
website, 60degreespharma.com, and our investor relations website, investors.worksport.com. This includes press releases
and other information about financial performance and governance matters and details related to our annual stockholder meetings. The information
contained on the websites referenced in this prospectus is not incorporated by reference into this filing. Further, our references to
website URLs are intended to be inactive textual references only.

<div align='center'>14</div>

Implications of Being an Emerging Growth Company and a Smaller Reporting Company We are an “emerging growth company,” as defined in the JOBS Act. We will remain an emerging growth company until the earlier of (i) the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act; (ii) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a